- idUS
- Listar por autor
Listar por autor "Calderón Cabrera, Cristina"
Mostrando ítems 1-4 de 4
-
Artículo
Differential cytogenetic profile in advanced chronic myeloid leukemia with sequential lymphoblastic and myeloblastic blast crisis
Calderón Cabrera, Cristina; Montero, I.; Morales, R. M.; Sánchez, J.; Carrillo, E.; Caballero Velázquez, Teresa; Prats, C.; Bernal, R.; De Blas, J. M.; Pérez Simón, José Antonio (Elsevier, 2013)Frequency of additional chromosomal abnormalities in chronic myeloid leukemia (CML) is estimated to be 7% in chronic phase ...
-
Artículo
Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation
Caballero Velázquez, Teresa; Calderón Cabrera, Cristina; López-Corral, L.; Puig, N.; Marquez-Malaver, F.; Pérez-López, E.; Pérez Simón, José Antonio (Springer Nature, 2020)This multicenter phase I trial was designed to evaluate the safety and efficacy of bortezomib (Bz) as part of both the ...
-
Artículo
Multivariable time-dependent analysis of the impact of azacitidine in patients with lower-risk myelodysplastic syndrome and unfavorable specific lower-risk score
Falantes, José F.; García Delgado, Regina; Calderón Cabrera, Cristina; Márquez Malaver, Francisco J.; Valcárcel, D.; De Miguel, Dunia; Bailén, Alicia; Bargay, Joan; Bernal, Teresa; González Porras, José R.; Tormo, Mar; Ramos, Fernando; Andreu, Rafael; Xicoy, Blanca; Nomdedeu, Benet; Brunet, Salut; Sánchez, Joaquín; Fernández Jurado, Antonio; Bonabad, Santiago; Pérez Simón, José Antonio; Sanz, Guillermo (Elsevier, 2015)Scoring systems for lower-risk myelodysplastic syndrome (LR-MDS) recognize patients with a poorer than expected outcome. ...
-
Tesis Doctoral
Nuevas modalidades de inmunoprofilaxis en trasplante: Inhibidores del proteosoma
Calderón Cabrera, Cristina (2017-09-22)El trasplante alogénico de progenitores hematopoyéticos es una opción potencialmente curativa para numerosos pacientes con ...